Does hyperthyroidism increase risk of death due to the ingestion of ecstasy?
Teri L Martin, David A Chiasson, Stephen J. Kish
Journal of Forensic Sciences July 2007 DOI: 10.1111/j.1556-4029.2007.00463.x (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case report Peer reviewed |
|---|---|
| Sample size | 1 |
| Population | A 24-year-old woman who died after MDMA use |
| Intervention | MDMA |
| Topics | MDMA |
| Key findings | The authors suggest that pre-existing hyperthyroidism (Graves' disease found at autopsy) predisposed this woman to fatal ecstasy-induced hyperthermia, and propose that a pre-existing defect affecting temperature status could be one factor in some ecstasy intoxication deaths. They state that cause and effect cannot be established. |
Abstract
Ecstasy (3,4-methylenedioxymethamphetamine, MDMA) is a psychoactive amphetamine derivative widely used for recreational purposes. Deaths caused by acute drug intoxication with MDMA are rare but can often involve a severe hyperthermic episode. The factors underlying the increased risk of some ecstasy users to a fatal drug reaction are not known. We present a case report of a 24-year-old woman who developed fatal hyperthermia with multi-organ complications following MDMA use and was found at autopsy to have diffuse thyroid hyperplasia (Graves' disease). An antemortem blood MDMA concentration of 0.68 mg/L was measured in a sample obtained on admission to hospital. Although a cause and effect cannot be established, as the thyroid hormone is a major regulator of thermogenesis, we suggest that hyperthyroidism predisposed the subject to ecstasy-induced hyperthermia and that a pre-existing defect affecting temperature status could be one factor in explaining some ecstasy intoxication deaths.
Comparable studies
Other case reports and case series on MDMA, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA Individuals whose deaths were associated with MDMA or MDEA use | 1987 | Case series | n = 5 |
| Pathology of deaths associated with "ecstasy" and "eve" misuse. Young white men aged 20 to 25 who died after using ring-substituted amphetamines (MDMA... | 1996 | Case series | n = 7 |
| 'Eve' and 'Ecstasy' Individuals who died after using MDMA or MDEA | 1987 | Case series | n = 5 |
| A Method of Conducting Therapeutic Sessions with MDMA Clients with clear therapeutic purpose, excluding those with serious functional... | 1998 | Case study | n = 2 |
| Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’) Psychiatric patients presenting between 1990 and 1992 whose symptoms developed in the... | 1994 | Case series | n = 13 |
Citations in the library
Cited by 6
- Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans British Journal of Pharmacology March 8, 2012
- Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study Journal of Psychopharmacology October 2, 2008
- Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans: Lost in translation British Journal of Pharmacology September 6, 2013
- From Bench to Bedside: Understanding the Science behind the Pharmacologic Management of MDMA- and other Sympathomimetic-Mediated Hyperthermia Journal of Pharmacy Technology May 1, 2011
- A fatal case of myocardial damage due to misuse of the "designer drug" MDMA. Legal medicine (Tokyo, Japan) November 2009
and 1 more in the library
Cites 4
- Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user Neurology July 25, 2000
- Ecstasy (MDMA) Deaths in New York City: A Case Series and Review of the Literature Journal of Forensic Sciences 2002
- The health effects of ecstasy: a literature review. Drug and Alcohol Review March 2002
- Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). The Lancet August 15, 1992